Literature DB >> 20199804

Prevalence and distribution of human papillomavirus types in cervical cancer, squamous intraepithelial lesions, and with no intraepithelial lesions in women from Southern Mexico.

Berenice Illades-Aguiar1, Luz del Carmen Alarcón-Romero, Verónica Antonio-Véjar, Noelio Zamudio-López, Natividad Sales-Linares, Eugenia Flores-Alfaro, Gloria Fernández-Tilapa, Amalia Vences-Velázquez, José Francisco Muñoz-Valle, Marco-Antonio Leyva-Vázquez.   

Abstract

OBJECTIVE: This study was to establish the frequency of HPV infection and which HPV types are circulating in women with cervical cancer (CC), with squamous intraepithelial lesions (SIL), and with no intraepithelial lesion (non-IL) from the State of Guerrero in Southern Mexico. Additionally, we investigated the frequency and distribution of HPV 16 intratypic variants found in this population.
METHODS: This cross-sectional study was conducted in 4150 women who attended five public health centers seeking cytological screening or for gynecological complaints. Pap smears or biopsies, as appropriate, were obtained for cytological and/or histological diagnosis. HPV detection was done by MY09/11 and GP5+/GP6+ PCR systems and typing by restriction fragment length polymorphism or DNA sequencing. HPV 16 variants were also analyzed.
RESULTS: HPV was found in 100% of CC, 83.5% in HSIL, 94.5% in LSIL, and 40.9% in non-IL. HR-HPV was the most frequent in all groups. HPV 16 was the most commonly identified HPV genotype in CC and HSIL. HPV 33 was the most frequent in LSIL and non-IL. The highest HPV prevalence was found in the youngest women, HR-HPV and HPV 16 were more frequent in women less than 25 years and more than 55 years of age. The HPV 16 variants E, AA-a and AA-c were found, AA-c was found only in CC.
CONCLUSION: This study contributes to the knowledge of regional prevalence of HPV types in the whole spectrum of disease, which can be useful in the application of prophylactic vaccines against HPV and in the viral screening methods. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20199804     DOI: 10.1016/j.ygyno.2010.01.036

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  28 in total

Review 1.  Cell-free nucleic acids as biomarkers in cancer patients.

Authors:  Heidi Schwarzenbach; Dave S B Hoon; Klaus Pantel
Journal:  Nat Rev Cancer       Date:  2011-05-12       Impact factor: 60.716

2.  Expression of E6, p53 and p21 proteins and physical state of HPV16 in cervical cytologies with and without low grade lesions.

Authors:  Diana K Jiménez Tagle; Daniel Hernández Sotelo; Berenice Illades-Aguiar; Marco A Leyva-Vazquez; Eugenia Flores Alfaro; Yaneth Castro Coronel; Oscar Del Moral Hernández; Luz Del Carmen Alarcón Romero
Journal:  Int J Clin Exp Med       Date:  2014-01-15

3.  Human papilloma virus genotypes in women from Nayarit, Mexico, with squamous intraepithelial lesions and cervical cancer.

Authors:  Laura Ortega-Cervantes; Adriana Aguilar-Lemarroy; Aurora Elizabeth Rojas-García; Briscia Socorro Barrón-Vivanco; Verónica Vallejo-Ruiz; David Cantú-De León; Yael Yvette Bernal Hernández; Armando Jáuregui-Martínez; Irma Martha Medina-Díaz
Journal:  Int J Health Sci (Qassim)       Date:  2016-07

4.  Nuclear expression of Rac1 in cervical premalignant lesions and cervical cancer cells.

Authors:  Miguel A Mendoza-Catalán; Gema R Cristóbal-Mondragón; Jesús Adame-Gómez; Heidi N del Valle-Flores; José Fco Coppe; Laura Sierra-López; Mirna A Romero-Hernández; Luz del Carmen Alarcón-Romero; Berenice Illades-Aguiar; Eduardo Castañeda-Saucedo
Journal:  BMC Cancer       Date:  2012-03-23       Impact factor: 4.430

5.  Prevalence of human papillomavirus in women from Mexico City.

Authors:  María Guadalupe López Rivera; Maria Olivia Medel Flores; José D'Artagnan Villalba Magdaleno; Virginia Sánchez Monroy
Journal:  Infect Dis Obstet Gynecol       Date:  2012-07-02

6.  Prevalence and correlation of human papillomavirus genotypes with clinical factors in cervical samples from Mexican women.

Authors:  Fabiola Hernández-Rosas; Erika Orozco-Hernández; Liliana Maza-Sánchez; Pamela Citlalli Salgado-García; Enrique Navarro-Vidal; Mercedes Piedad de León-Bautista
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-22

7.  HPV molecular detection from urine versus cervical samples: an alternative for HPV screening in indigenous populations.

Authors:  Francisco I Torres-Rojas; Miguel A Mendoza-Catalán; Luz Del C Alarcón-Romero; Isela Parra-Rojas; Sergio Paredes-Solís; Marco A Leyva-Vázquez; Jair E Cortes-Arciniega; Carlos J Bracamontes-Benítez; Berenice Illades-Aguiar
Journal:  PeerJ       Date:  2021-06-17       Impact factor: 2.984

8.  E6/E7 Variants of Human Papillomavirus 16 Associated with Cervical Carcinoma in Women in Southern Mexico.

Authors:  Ramón Antaño-Arias; Oscar Del Moral-Hernández; Julio Ortiz-Ortiz; Luz Del Carmen Alarcón-Romero; Jorge Adán Navor-Hernández; Marco Antonio Leyva-Vázquez; Marco Antonio Jiménez-López; Jorge Organista-Nava; Berenice Illades-Aguiar
Journal:  Pathogens       Date:  2021-06-20

9.  The integration of HR-HPV increases the expression of cyclins A and E in cytologies with and without low-grade lesions.

Authors:  M I Zubillaga-Guerrero; B Illades-Aguiar; M A Leyva-Vazquez; E Flores-Alfaro; E Castañeda-Saucedo; J F Muñoz-Valle; L C Alarcón-Romero
Journal:  J Cytol       Date:  2013-01       Impact factor: 1.000

10.  Prevalence of human papillomavirus in the cervical epithelium of Mexican women: meta-analysis.

Authors:  Raúl Peralta-Rodríguez; Pablo Romero-Morelos; Vanessa Villegas-Ruíz; Mónica Mendoza-Rodríguez; Keiko Taniguchi-Ponciano; Beatriz González-Yebra; Daniel Marrero-Rodríguez; Mauricio Salcedo
Journal:  Infect Agent Cancer       Date:  2012-12-03       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.